New combo could ease pain after rhinoplasty
NCT ID NCT07380139
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests whether adding either dexamethasone or dexmedetomidine to the numbing drug bupivacaine can improve pain control after rhinoplasty (nose job). The study will enroll 90 adults undergoing nose surgery. The main goal is to see how long it takes before patients need their first dose of extra pain medicine after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexamethasone, dexmedetomidine, bupivacaine
- What this could lead to
- If it works, this could point toward a better way to manage pain after nose surgery, potentially reducing the need for additional painkillers.
- What could go wrong
- This is a very early Phase 1 trial with only 90 people, so results may not apply to everyone. The study focuses on timing of pain relief, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-OPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams University
Cairo, 11122, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cold therapy and special rinses tame tooth pain after pulpotomy?
- Could a playlist be the new Post-Surgery comfort?
- Can a new nerve block ease pain after lung surgery?
- A shot that might dull post-surgery pain and cut opioid use in teens
- Chilled solution or steroid: which eases Post-Root-Canal pain?
- Chest nerve block may slash opioid use after heart surgery